학술논문

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration
Document Type
Article
Source
In: International Immunopharmacology. (International Immunopharmacology, 10 May 2024, 132)
Subject
Language
English
ISSN
18781705
15675769